CELLDEX THERAPEUTICS INC NEW filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by CELLDEX THERAPEUTICS INC NEW (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-14RTW INVESTMENTS, LPCelldex Therapeutics, Inc.3,463,2016.3%EDGAR
SC 13G/A2024-02-14Point72 Asset Management, L.P.Celldex Therapeutics, Inc.2,756,1225.0%EDGAR
SC 13G2024-02-14Kynam Capital Management, LPCelldex Therapeutics, Inc.3,005,9045.5%EDGAR
SC 13G2024-02-14EVENTIDE ASSET MANAGEMENT, LLCCelldex Therapeutics, Inc.3,630,0136.6%EDGAR
SC 13G/A2024-02-13VANGUARD GROUP INCCelldex Therapeutics, Inc.3,046,3315.6%EDGAR
SC 13G2024-02-13Polar Capital Holdings PlcCelldex Therapeutics, Inc.3,135,8715.7%EDGAR
SC 13G/A2024-02-09FMR LLCCelldex Therapeutics, Inc.7,050,40912.9%EDGAR
SC 13G/A2024-02-08WELLINGTON MANAGEMENT GROUP LLPCelldex Therapeutics, Inc.6,476,56111.8%EDGAR
SC 13G/A2024-01-26BlackRock Inc.Celldex Therapeutics, Inc.3,675,6926.7%EDGAR
SC 13G2023-11-20Point72 Asset Management, L.P.Celldex Therapeutics, Inc.3,622,1366.6%EDGAR
SC 13G/A2023-05-10WELLINGTON MANAGEMENT GROUP LLPCelldex Therapeutics, Inc.4,781,49710.1%EDGAR
SC 13G/A2023-02-14RTW INVESTMENTS, LPCelldex Therapeutics, Inc.3,084,2156.5%EDGAR
SC 13G/A2023-02-14VIKING GLOBAL INVESTORS LPCelldex Therapeutics, Inc.00.0%EDGAR
SC 13G/A2023-02-09FMR LLCCelldex Therapeutics, Inc.7,064,97415.0%EDGAR
SC 13G/A2023-02-09VANGUARD GROUP INCCelldex Therapeutics, Inc.2,513,5645.3%EDGAR
SC 13G2023-02-06WELLINGTON MANAGEMENT GROUP LLPCelldex Therapeutics, Inc.4,647,9129.9%EDGAR
SC 13G/A2023-02-01STATE STREET CORPCelldex Therapeutics, Inc.-4.9%EDGAR
SC 13G/A2023-02-01BlackRock Inc.Celldex Therapeutics, Inc.3,224,7166.8%EDGAR
SC 13G2022-06-10VIKING GLOBAL INVESTORS LPCelldex Therapeutics, Inc.2,366,3855.1%EDGAR
SC 13G/A2022-02-14RTW INVESTMENTS, LPCelldex Therapeutics, Inc.3,921,5798.4%EDGAR
External links